Yunye Mao

4PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 02, 2026
Efficacy and safety of immunotherapy in elderly patients with advanced non-small cell lung cancer: a real-world study stratified by age.

Yi Dong, Mei-Cen Liu, Yun-Ye Mao

|Feb 12, 2026
Grade 3 and above opportunistic pneumonia or drug-induced interstitial lung disease during tyrosine-kinase inhibitor treatment for advanced non-small-cell lung cancer with RET fusion mutations: coexistence of risks and opportunities.

An Wang, Tao Li, Yun-Ye Mao

|Jul 28, 2025
Systematic pan-cancer analysis identified NCOA4 as an immunological and prognostic biomarker and validated in lung adenocarcinoma.

An Wang, Yun-Ye Mao, Tao Li

|Jul 23, 2025
PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis.

Yunye Mao, An Wang, Xiangwei Ge

Pageof 1

Frequent Collaborators

4 joint publications

Yi Hu

3 joint publications

An Wang

3 joint publications

Tao Li

1 joint publications

Fan Zhang